BREAKING: FDA Approves CBD-Based Medicine Derived from Marijuana
BREAKING: FDA Approves CBD-Based Medicine Derived from Marijuana Written by Orion Inskip, Attorney at Gleam Law, PLLC. The Food and Drug Administration (FDA) has approved
BREAKING: FDA Approves CBD-Based Medicine Derived from Marijuana Written by Orion Inskip, Attorney at Gleam Law, PLLC. The Food and Drug Administration (FDA) has approved
The FDA’s regulation of the CBD market has taken its toll on a heavy hitter in the marketplace. Curaleaf, which is sold in CVS Health stores, was
Why Trademark Distinctiveness Matters A strong trademark is a valuable asset that can elevate the reputation of a company and influence consumer decisions. When developing
Update on Hemp Banking On December 3, 2019, the Federal Deposit Insurance Corporation (FDIC) issued a letter to financial institutions highlighting the interagency guidance on
Virginia Governor Signs Bill Regulating CBD as Food Virginia Governor Ralph Northam has signed a bill into law that would classify CBD as food. The importance of
The FDA recently sent warning letters two four CBD companies. Written by Orion Inskip, Attorney at Gleam Law, PLLC. The Federal Drug Administration (FDA) regulates
